| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/27/2006 | US7067280 Human cartilage glycoprotein |
| 06/27/2006 | US7067270 Method for detecting protein |
| 06/27/2006 | US7067268 immunoglobulins for neutralizing arachidonic acid metabolite releasing activity of the 19P2 ligand; used as diagnostic, prophylactic, therapeutic agents for diseases caused by abnormality in the pituitary function modulating activity (prolactin secretion promoting activity) |
| 06/27/2006 | US7067265 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 06/27/2006 | US7067255 Hereditary hemochromatosis gene |
| 06/27/2006 | US7067138 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| 06/27/2006 | US7067136 Proteins; gene expression of antigen in vivo; genetic engineering; detection of antibiotics ; drug design; plasmids |
| 06/27/2006 | US7067135 RAP (RNAIII activating protein) polypeptide of amino acid sequence 13 |
| 06/27/2006 | US7067133 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier |
| 06/27/2006 | US7067132 Binding to muteins; prevent signal transduction; monoclonal antibodies; graft versus host disease; antiarthritic agents; antidiabetic agents; skin disorders; autoimmune disease; inflammatory bowel disorders; anticancer agents |
| 06/27/2006 | US7067131 Methods for using anti-MUC18 antibodies |
| 06/27/2006 | US7067130 Genetic engineering; polypeptide; cancer diagnosis |
| 06/27/2006 | US7067128 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/27/2006 | US7067127 Amino and nucleotide sequences; isolated, hybrid nucleic acid; purification of enzyme |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067113 Antiinflammatory agents; anticancer agents; congestive heart failure; genetic disorders; contacting with dpamine receptors; determination binding; calibration |
| 06/27/2006 | US7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 06/27/2006 | CA2283740C Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 06/27/2006 | CA2237224C Synthetic hpv11 virus-like particles |
| 06/27/2006 | CA2124034C Gene coding for a protein regulating aureobasidin sensitivity |
| 06/22/2006 | WO2006066229A2 Elicitation of antibodies to self peptides by immunization with dendritic cells |
| 06/22/2006 | WO2006066171A1 Amyloid βετα antibodies for use in improving cognition |
| 06/22/2006 | WO2006066089A1 Humanized amyloid beta antibodies for use in improving cognition |
| 06/22/2006 | WO2006066086A1 Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| 06/22/2006 | WO2006066078A2 Fcϝriib-specific antibodies and methods of use thereof |
| 06/22/2006 | WO2006066065A2 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 06/22/2006 | WO2006065975A2 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 06/22/2006 | WO2006065208A1 Purification of immunoglobulins |
| 06/22/2006 | WO2006064136A1 Production of antibody formats and immunological applications of said formats |
| 06/22/2006 | WO2006064121A2 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 06/22/2006 | WO2006063844A1 Soluble hla-e molecules and their use for diagnosing and treating pathologies |
| 06/22/2006 | WO2006063518A1 Multifunctional polypeptides |
| 06/22/2006 | WO2006063462A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 06/22/2006 | WO2006063415A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 06/22/2006 | WO2006048757A3 Anti-bacterial vaccine compositions |
| 06/22/2006 | WO2006042158A3 Methods and compositions for improving recombinant protein production |
| 06/22/2006 | WO2006034232A3 Diagnostic marker |
| 06/22/2006 | WO2006029005A3 Promoter substitution for immunoglobulin therapy |
| 06/22/2006 | WO2006014678A3 Compositions and methods of using angiopoietin-like 4 protein |
| 06/22/2006 | WO2006002177A3 Interferon alpha receptor 1 antibodies and their uses |
| 06/22/2006 | WO2005121177A3 Anti-il-13 antibodies, crystals of anti-il-13 antibodies and complexes comprising them |
| 06/22/2006 | WO2005118887A3 Human antibodies interacting with hiv gp41 |
| 06/22/2006 | WO2005117978A3 Method for treating multiple sclerosis |
| 06/22/2006 | WO2005110481A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 06/22/2006 | WO2005091853A3 Methods and compositions for treating il-13 related pathologies |
| 06/22/2006 | WO2005062955A3 Agonist anti-trkc antibodies and methods using same |
| 06/22/2006 | WO2005021709A9 Cln101 antibodies |
| 06/22/2006 | WO2004101738A3 Domain-exchanged binding molecules, methods of use and methods of production |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | WO2004032868A3 Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 06/22/2006 | US20060137029 Novel G protein-coupled receptor encoding gene and diagnostic uses therefor |
| 06/22/2006 | US20060135756 Mammalian cell surface antigens; related reagents |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135746 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 06/22/2006 | US20060135459 Targeted innate immunity |
| 06/22/2006 | US20060135431 Peptides and related molecules that bind to TALL-1 |
| 06/22/2006 | US20060135430 BLy antagonists and uses thereof |
| 06/22/2006 | US20060135411 Administering an effective amount of the compound AcPhe[Orn-Pro-D-Cyclohexylalanine-Trp-Arg] to a subject in need thereof; cyclic peptidic and peptidomimetic compounds have the ability to modulate the activity of G protein-coupled receptors |
| 06/22/2006 | US20060134780 For producing high affinity, fully human antibodies of a desired isotype in response to immunization with any virtually any desired antigen |
| 06/22/2006 | US20060134756 Anti-IL-20 antibodies and binding partners and methods of using in inflammation |
| 06/22/2006 | US20060134755 IL-17 homologous polypeptides and therapeutic uses thereof |
| 06/22/2006 | US20060134751 Identification of novel MS4A gene family members expressed by hematopoietic cells |
| 06/22/2006 | US20060134709 Molecules having a variant Fc region, wherein region comprises at least one amino acid modification relative to a wild-type Fc region; modified molecules confer an effector function to a molecule, where the parent molecule does not detectably exhibit this effector function; utility in cancer treatment |
| 06/22/2006 | US20060134707 Hybridoma cell lines; rapid test kits |
| 06/22/2006 | US20060134706 Atopic dermatitis inducer |
| 06/22/2006 | US20060134704 Microwell array chip for detecting antigen-specific lymphocytes, method of detecting and method of manufacturing antigen-specific lymphocytes, and method of cloning antigen-specific lymphocyte antigen receptor genes |
| 06/22/2006 | US20060134700 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 06/22/2006 | US20060134699 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
| 06/22/2006 | US20060134125 Purification of antigen-specific T cells |
| 06/22/2006 | US20060134124 Immunosuppression |
| 06/22/2006 | US20060134123 Comprise the gene of interest and a viral capsid or envelope carrying a member of a specific binding pair, the counterpart of which is not directly associated with the surface of the target cell; used in gene therapy |
| 06/22/2006 | US20060134122 Peptides of syndecan-1 for inhibition of cancer |
| 06/22/2006 | US20060134121 DII4 antagonists, assays, and therapeutic methods thereof |
| 06/22/2006 | US20060134119 Drugs containing galectin 9 |
| 06/22/2006 | US20060134118 using a monoclonal antibody or an antigen-binding portion which binds to an epitope of EphB4 polypeptide and inhibiting the growth of cancer as a result of such binding by causing cell death |
| 06/22/2006 | US20060134117 Preventives/remedies for cancer |
| 06/22/2006 | US20060134116 Ca 125 tumor antigen function and uses thereof |
| 06/22/2006 | US20060134113 Preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 06/22/2006 | US20060134110 CD55-Interaction partners and the uses thereof |
| 06/22/2006 | US20060134107 Immunoglobulins devoid of light chains |
| 06/22/2006 | US20060134105 IgG immunoglobulin variants with optimized effector function |
| 06/22/2006 | US20060134104 for identifying and/or using inhibitors of the HGF/c-met signaling pathway; a mesenchyme-derived pleiotrophic factor with mitogenic, motogenic and morphogenic activities on a number of different cell types |
| 06/22/2006 | US20060134103 Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands |
| 06/22/2006 | US20060134102 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 06/22/2006 | US20060134101 Use of avian antibodies |
| 06/22/2006 | US20060134100 Dc-sign blockers and their use for preventing or treating viral infections |
| 06/22/2006 | US20060134099 Production of rabies antibodies in plants |
| 06/22/2006 | US20060134094 Fibrin material and method for producing and using the same |
| 06/22/2006 | US20060133994 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 06/22/2006 | DE10111083B4 Chitindeacetylase und Verfahren zu seiner Herstellung Chitin deacetylase and process for its preparation |
| 06/22/2006 | CA2591918A1 Cancer-specific spanx-n markers |
| 06/22/2006 | CA2591659A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 06/22/2006 | CA2591587A1 Methods for treating autoimmune disorders |
| 06/22/2006 | CA2590935A1 Fc.gamma.riib-specific antibodies and methods of use thereof |
| 06/22/2006 | CA2590751A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 06/22/2006 | CA2590615A1 Production of antibody formats and immunological applications of said formats |
| 06/22/2006 | CA2590337A1 Humanized amyloid beta antibodies for use in improving cognition |
| 06/22/2006 | CA2590303A1 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 06/22/2006 | CA2589017A1 Amyloid beta antibodies for use in improving cognition |